Find Resources
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
This paper analyzes the policy components that contribute to the programmatic success of flu and Tdap pregnancy vaccine programs in three high-income countries, including the United States. Key pillars to increased vaccination coverage include Health Authority accountability, facilitated patient access to vaccination, healthcare professional accountability and engagement, awareness of the burden and severity of diseases, and finally, belief in the benefits of pregnancy vaccination. In the US, given the higher diversity of stakeholders, a multi-stakeholder approach with calls to action from the CDC and endorsement from other scientific societies were key to uptake of vaccinations in pregnancy. It is recommended that maternal task forces reinforce these messages, disseminate toolkits, and that partners address barriers that stand in the way of vaccination, including ensuring that vaccination clinics are convenient for pregnant woman. Successful programs do not require implementation of all components; instead, public health experts should use these as components as guiding tools that can be refined depending on the specificities of the healthcare system in place.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study, Summary Report/Recommendations
The guidance outlined in this report provides a roadmap for the ethical inclusion of pregnant women’s experiences in in the development and deployment of vaccines against emerging viruses. Recommendations include bolstering health information surveillance systems, stakeholder engagement with health care, women, families and communities, and changing the narrative about pregnancy and clinical research efforts. Recommendations require commitment of financial resources, addressing inequities in public health and whenever possible, the inclusion of perspectives of pregnant women. Lastly, the authors recommend that “When there is a limited supply of vaccine against a pathogenic threat that disproportionately affects pregnant women, their offspring, or both, or when only one vaccine among several is appropriate for use in pregnancy, then pregnant women should be among the priority groups to be offered the vaccine.” This prioritization process is key to addressing inequities and are guidance for future pandemic response efforts.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study
Maternity healthcare professionals (MHCPs) play an important role in promoting vaccines and influencing the perspectives of pregnant women. This systematic review outlines the views and experiences of these key workforce members involved in the provision of the maternal influenza vaccine worldwide. In order to promote vaccine uptake, results indicate that it is important to educate MHCPs, ensure there is sufficient time for discussions, and implement electronic vaccination prompts. These, in addition to national policies and guidelines, helped increase the confidence of these professionals in recommending vaccination.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
The guidance outlined in this report provides a roadmap for the ethical inclusion of pregnant women’s experiences in the development and deployment of vaccines against emerging viruses. Recommendations include (1) bolstering health information surveillance systems, (2) stakeholder engagement with health care, women, families and communities, and (3) changing the narrative about pregnancy and clinical research efforts. Recommendations require commitment of financial resources, addressing inequities in public health, and whenever possible, the inclusion of perspectives of pregnant women. Lastly, the authors recommend that “When there is a limited supply of vaccine against a pathogenic threat that disproportionately affects pregnant women, their offspring, or both, or when only one vaccine among several is appropriate for use in pregnancy, then pregnant women should be among the priority groups to be offered the vaccine.” This prioritization process is key to addressing inequities and are guidance for future pandemic response efforts.
Novel Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and are in the process of generating evidence of effectiveness or may not yet be tested.
RELEASE DATE:
Peer Review Study
Survey on the impact of COVID-19 on pregnant women that can be adapted to assessing the experiences of this population in future crises. This article discusses the findings of a survey distributed to 1,439 Dutch women who were pregnant between April 4-May 10, 2020. The survey included multiple scales, such as the COVID-19 and Perinatal Experiences scale, the State-Trait Anxiety Inventory, and the Edinburgh Depression Scale, and compared results with a similar survey completed in 2018. The survey included 8 key domain areas, including topics like financial stress, social support, partner support, anxiety symptoms, and depressive symptoms, to name a few. Women reported higher worries related to COVID-19 in general, and also reported higher work/financial related worries. Depression and anxiety also increased, with anxiety rates increasing two-fold.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
This study recommends that governments should continue to fund and prioritize use of Federally Qualified Health Centers (FQHCs) as major vaccine administration sites. This retrospective cohort study examines COVID-19 vaccination administration rates at FQHCs by race and ethnicity and also the racial and ethnic equity in vaccine receipt at FQHCs. The results of the study found that vaccine administration at FQHCs was equitable for American Indian or Alaska Native, Asian, and Hispanic populations, but there were inequities for the Black population. FQHCs have provided critical access to COVID-19 vaccinations for patients from diverse racial and ethnic groups. This resource may help motivate governments to continue funding and prioritizing the use of FQHCs by showing that these health centers have provided access to COVID-19 vaccinations for patients from diverse economic, racial, and ethnic groups.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study
The authors assess racial and ethnic disparities in four experience-of-care metrics among Medicaid managed care enrollees and estimate the extent to which overall disparities may be attributed to within-plan disparities versus between-plan disparities.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Peer Review Study
The authors assessed intent to be vaccinated and concerns among members of seven U.S. racial and ethnic groups (1,000 Black, 500 American Indian/Alaska Native, 1,000 Asian, 1,000 Latino [500 English-speaking and 500 Spanish-speaking], 500 Pacific Islander, 500 multiracial, and 1,000 White adults) in the COVID-19′s Unequal Racial Burden (CURB) survey conducted December 2020-February 2021.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study
This study details a national, state-level analysis of COVID-19 infection and mortality disparities between ethnic and racial subgroups using data from the COVID Tracking Project. Results found significantly higher rates of COVID-19 infections among Hispanic and African American populations. A choropleth map of disparities in the United States was produced as part of the study.